Top

Reactions Weekly

Published in:

01-04-2015 | Case report

Lamivudine

Lamivudine Resistance in chronic active hepatitis B: case report

Published in: Reactions Weekly | Issue 1/2015

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

…

Fen L. Viral relapse and genetic resistance after a nearly 8-year cessation of lamivudine therapy in a patient with chronic hepatitis B: a case report]. . Zhonghua Gan Zang Bing Za Zhi 22: 464-465, No. 6, Jun 2014 [Chinese; summarised from a translation] - ChinaPubMed

Title: Lamivudine
Lamivudine Resistance in chronic active hepatitis B: case report
Publication date: 01-04-2015
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2015
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-015-9238-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lamivudine

Lamivudine Resistance in chronic active hepatitis B: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2015

Vismodegib

Paracetamol

Afamelanotide

Doxycycline

Vemurafenib

Bevacizumab